1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. Spineway
  6. News
  7. Summary
    ALSPW   FR0011398874

SPINEWAY

(ALSPW)
  Report
Real-time Euronext Paris  -  05/23 08:49:09 am EDT
0.000500 EUR    0.00%
04/152022 FIRST QUARTER : Income increase by 55%
AQ
04/15Spineway SA Announces Unaudited Revenue Results for the First Quarter of 2022
CI
04/15SPINEWAY : 1st quarter earnings
CO
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensus 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Spineway : Expansion in Asia

02/11/2021 | 12:40pm EDT

Press release                                                                           Ecully, February 11th, 2021 – 6:30 p.m.


Continued expansion in Asia :

  • First implantation of the Mont Blanc 3D+ in Thailand
  • Signature of an Exclusive Distribution Agreement in Malaysia

Spineway, specialized in the treatment of severe disorders of the spine, announces the first surgery in Thailand with Mont Blanc 3D+ instrumentation as well as the signature of an exclusive distribution agreement for the marketing of its products in Malaysia.

This operation was successfully performed on February 4th, 2021 by Dr Chatchawarl Sarntipiphat, orthopedic surgeon at Srinagarind University Hospital in Khon Kaen Province, Thailand, on an 11-year-old patient with idiopathic scoliosis.

Doctor Sarntipiphat specifies the context of this operation : “This type of scoliosis requires a surgical correction because the permanent deviation of the spine can cause a deformation of the vertebral bodies, especially during the child's growth period. Particularly indicated for this type of pathology, Spineway's patented Mont Blanc 3D+ implant makes it possible to correct the deformity while keeping the natural curves of the spine.”

Present in Thailand since 2016 through exclusive distribution, Spineway continues to develop its know-how on the Asian continent with the implementation of a national distribution agreement within the main healthcare centers in Malaysia, a few months after the signing of an exclusive commercial agreement for the sale of its products in Japan1. Spineway and its partner will promote and introduce the whole product portfolio, in particular, the specific solutions for mini-invasive surgery Mont-Blanc MIS.

Stéphane Le Roux, CEO of Spineway, says : “We are delighted with this partnership in Malaysia, a country recognized as having one of the best healthcare systems in Asia. Our Mont-Blanc MIS and MISTI platform designed by Spineway will address the market needs by providing advanced surgical techniques to surgeons and patients”.

Sales are scheduled to start in June 2020, immediately after the product registration will be granted by the Medical Device Authority in Malaysia.

This first implantation of the Mont Blanc 3D+ in Thailand and this new distribution agreement in Malaysia demonstrate that Spineway continues its development in Asia thanks to the high added value of its technologies. 

Upcoming: April 15th, 2021 - Publication of first quarter 2021 revenues
March 8th, 2021 – General meeting

The annual accounts and and the preparatory documents for the Shareholders' Meeting
are available on the company’s website in the Investors

SPINEWAY IS ELIGIBLE FOR THE PEA-PME (EQUITY SAVINGS PLANS FOR SMES)
Find out all about Spineway at www.spineway.com

This press release has been prepared in both English and French. In case of discrepancies, the French version shall prevail.

Spineway designs, manufactures and markets innovative implants and surgical instruments for treating severe disorders of the spinal column.
Spineway has an international network of over 50 independent distributors and 90% of its revenue comes from exports.
Spineway, which is eligible for investment through FCPIs (French unit trusts specializing in innovation), has received the OSEO Excellence award since 2011 and has won the Deloitte Fast 50 award (2011). Rhône Alpes INPI Patent Innovation award (2013) – INPI Talent award (2015).
ISIN: FR0011398874 - ALSPW

Contacts:

SPINEWAY

Shareholder-services line
Available Tuesday through Thursday
(10 a.m.12 p.m.)
+33 (0)811 045 555
Eligible PEA / PME

ALSPW


Euronext Growth


AELIUM 

Finance & Communication

Investor relations
Solène Kennis
spineway@aelium.fr


<hr />



1 Press release of April 23, 2020


Attachment

  • SPW_CP_Malaisie_VD_UK

© OMX, source GlobeNewswire - EU Press Releases

All news about SPINEWAY
04/152022 FIRST QUARTER : Income increase by 55%
AQ
04/15Spineway SA Announces Unaudited Revenue Results for the First Quarter of 2022
CI
04/15SPINEWAY : 1st quarter earnings
CO
03/23Lack of quorum at the Combined General Meeting as of March 23, 2022 - 2nd invitation o..
AQ
02/16General Meeting
AQ
02/02SPINEWAY : Financial report
CO
02/012021 SPINEWAY FISCAL YEAR RESULTS : significant improvement and sound dynamic
AQ
02/01Spineway SA Reports Earnings Results for the Full Year Ended December 31, 2021
CI
01/184th 2021 quarter turnover rise of 26% consistent with the annual revenue growth by 27%
AQ
01/18Spineway Reports Unaudited Revenue Results for the Fourth Quarter and Full Year 2021
CI
More news
Financials
Sales 2021 5,04 M 5,31 M 5,31 M
Net income 2021 -1,58 M -1,67 M -1,67 M
Net cash 2021 11,6 M 12,3 M 12,3 M
P/E ratio 2021 -6,72x
Yield 2021 -
Capitalization 7,88 M 8,31 M 8,31 M
EV / Sales 2020 0,41x
EV / Sales 2021 0,10x
Nbr of Employees 27
Free-Float 42,8%
Chart SPINEWAY
Duration : Period :
Spineway Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SPINEWAY
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 1
Last Close Price 0,00 €
Average target price 0,01 €
Spread / Average Target 1 588%
Managers and Directors
Stéphane Le Roux Chairman & Chief Executive Officer
Myriam Denis-Galland Chief Financial Officer
Joseph Brigneaud Independent Director
Bérangère Boggio Independent Director
Weiguang Guo Director
Sector and Competitors
1st jan.Capi. (M$)
SPINEWAY-37.50%8
ABBOTT LABORATORIES-19.54%198 277
MEDTRONIC PLC-0.89%137 548
BECTON, DICKINSON AND COMPANY2.66%71 922
HOYA CORPORATION-22.41%37 902
BAXTER INTERNATIONAL INC.-14.69%36 873